Dry Eye Test Strip
NDC Package 51801-008-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Dry Eye Test (fluorescein sodium) strips is for testing tear film stability by determining the fluorescein break-up time (FBUT). This formulation utilizes a strip delivery system. Marketed by Nomax Inc., this product is identified by NDC 51801-008.

Identification & Billing

NDC Package Code
51801-008-15
Package Description
50 POUCH in 1 CARTON / 2 STRIP in 1 POUCH
Product Code
11-Digit Billing Format
51801000815

Clinical Specifications

Proprietary Name
Dry Eye Test
Non-Proprietary Name
Fluorescein Sodium
Substance Name
Fluorescein Sodium
Dosage Form
Strip - A long narrow piece of material.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
Usage Information
For testing tear film stability by determining the fluorescein break-up time (FBUT).

Regulatory & Marketing

Labeler Name
Nomax Inc.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
12-05-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51801-008-15 identifies a specific commercial package of 50 pouch in 1 carton / 2 strip in 1 pouch of Dry Eye Test, a human prescription drug labeled by Nomax Inc.. This strip is formulated for ophthalmic use and contains fluorescein sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nomax Inc. on December 05, 2013. The current certification is valid through December 31, 2026.

How is this Nomax Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51801000815. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51801-008-15
11-Digit CMS (5-4-2)
51801-0008-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.